Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Anesthesiology|August 5, 2010
Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective studyPatrick Y Wuethrich, Shu-Fang Hsu Schmitz, Thomas M Kessler, et al.
The Prostate|May 1, 1997
Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinomaV Djonov, R K Ball, S Graf, et al.
The Prostate|June 1, 1997
Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutationsA E Mottaz, R Markwalder, M F Fey, et al.
European Urology|January 25, 2011
Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economicalFrédéric D Birkhäuser, Pascal Zehnder, Beat Roth, et al.
European Urology Focus|April 23, 2020
Functional Results, Complications Associated with the Serosa-lined Tunnel, and Quality of Life with a Cross-folded Ileal Reservoir Combined with an Afferent Tubular Isoperistaltic Segment for Heterotopic Continent Urinary Diversion: An Observational Long-term Cohort AnalysisMarc A Furrer, Ladina Noser, Benjamin Lyttwin, et al.
European Urology|January 16, 2009
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patientsHarriet C Thoeny, Maria Triantafyllou, Frederic D Birkhaeuser, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2012
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancerMaria Triantafyllou, Urs E Studer, Frédéric D Birkhäuser, et al.
European Urology|August 7, 2013
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancerFrédéric D Birkhäuser, Urs E Studer, Johannes M Froehlich, et al.
European Urology|October 24, 2003
Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility studyWalter Albrecht, Laurence Collette, Cesare Fava, et al.
European Urology|August 13, 2013
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-upUrs E Studer, Peter Whelan, Florian Wimpissinger, et al.
Pageof 30